GODAVARI DRUGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.5 INR | -0.41% |
|
+0.94% | +11.59% |
| Sales 2022 | 1.61B 19.33M | Sales 2023 | 1.6B 19.18M | Capitalization | 570M 6.84M |
|---|---|---|---|---|---|
| Net income 2022 | 52M 623K | Net income 2023 | 37M 444K | EV / Sales 2022 | 0.43 x |
| Net Debt 2022 | 208M 2.49M | Net Debt 2023 | 328M 3.93M | EV / Sales 2023 | 0.56 x |
| P/E ratio 2022 |
9.38
x | P/E ratio 2023 |
15.1
x | Employees | 104 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 37.58% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.41% | ||
| 1 week | +0.94% | ||
| Current month | +8.12% | ||
| 1 month | +3.43% | ||
| 3 months | +0.75% | ||
| 6 months | +13.04% | ||
| Current year | +11.59% |
1 week
97.55
102.98
1 month
93.51108.15
Current year
89.51114.00
1 year
76.21114.00
3 years
46.60114.00
5 years
9.00114.00
10 years
8.25114.00
| Managers | Title | Age | Since |
|---|---|---|---|
Mukund Kakani
CEO | Chief Executive Officer | 71 | 02/87/02 |
Mohit Jaju
DFI | Director of Finance/CFO | 52 | 10/12/10 |
| Compliance Officer | - | 29/23/29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 86 | - | |
Ghanshyam Jaju
CHM | Chairman | 77 | 02/87/02 |
Mukund Kakani
CEO | Chief Executive Officer | 71 | 02/87/02 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/24/02 | 100.5 | -0.41% | 6 058 |
| 30/24/30 | 100.9 | +0.04% | 6,266 |
| 29/24/29 | 100.9 | -1.32% | 14,018 |
| 26/24/26 | 102.2 | +2.19% | 18,923 |
| 25/24/25 | 100 | -0.45% | 12,601 |
Delayed Quote Bombay S.E., May 02, 2024 at 03:30 pm IST
More quotes
Godavari Drugs Limited is an India-based company, which is engaged in the business of manufacturing of active pharmaceutical ingredients (API) and its intermediates. The Company is engaged in the business of contract manufacturing, loan license manufacturing, manufacturing and supply of API, drug intermediaries and fine chemicals. The Company operates through manufacture and sale of API and its intermediates segment. The Company's manufacturing facilities are located at the Maharashtra Industrial Development Corporation estate at Nanded, Maharashtra, India. The facility has multiple production blocks for APIâs, drug intermediates and fine chemicals.
Sector
Pharmaceuticals
Calendar
29/05/2024
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +11.59% | 9.1M | |
| +20.61% | 43.18B | |
| +20.67% | 22.59B | |
| +14.56% | 14.56B | |
| +13.94% | 13.54B | |
| +43.35% | 11.5B | |
| -8.37% | 6.93B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.21% | 5.36B |
- Stock Market
- Equities
- GODAVARI6 Stock
